Literature DB >> 6309985

Serum factors from patients with systemic lupus erythematosus enhancing superoxide generation by normal neutrophils.

M Shingu, M Oribe, T Todoroki, K Tatsukawa, K Tomo-oka, M Yasuda, M Nobunaga.   

Abstract

It has been suggested that human neutrophils exposed to performed immune complexes or activated complement fragments generate O2- anions in extracellular medium. In vivo studies have revealed that oxygen intermediates produced by immune complex-activated neutrophils play an important role in subsequent tissue damage. Since it is difficult to obtain direct evidence that O2- is released into plasma in patients with systemic lupus erythematosus (SLE), we studied the capacities of their sera to stimulate O2- release by human neutrophils in vitro. Sera from patients with SLE significantly enhanced O2- generation by neutrophils compared to normal sera. The enhancing activity of serum in the induction of increased O2- generation correlated positively with the presence of serum immune complexes and negatively with serum complement levels. The enhancing factors were analyzed by serum fractionation on Sephadex G-200 gel filtration, and were concluded to be immune complexes of intermediate size containing an activated complement fragment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309985     DOI: 10.1111/1523-1747.ep12517989

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients.

Authors:  Nadine Glesse; Paula Rohr; Odirlei André Monticielo; Tássia Flores Rech; João Carlos Tavares Brenol; Ricardo Machado Xavier; Kátia Kvitko; José Artur Bogo Chies
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

Review 2.  The beneficial role of vitamin D in systemic lupus erythematosus (SLE).

Authors:  Khanh vinh quốc Luong; Lan Thi Hoàng Nguyễn
Journal:  Clin Rheumatol       Date:  2012-07-17       Impact factor: 2.980

3.  Intracellular contents of cyclic nucleotides in neutrophils and lymphocytes from patients with systemic lupus erythematosus.

Authors:  M Shingu; K Tatsukawa; M Nobunaga
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  New lymphokines produced by SLE sera stimulated lymphocytes: the PNAF (polymorphonuclear activating factors).

Authors:  M T Labro-Bryskier; C Babin-Chevaye; J Hakim
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

5.  Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.

Authors:  M Shingu; M Nobunaga
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

6.  Rheumatoid factor modulation of neutrophil superoxide generation enhancing activity of preformed immune complexes.

Authors:  S Oishi; M Shingu; I Ezaki; M Nobunaga; K Sakai
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

7.  Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide.

Authors:  M Shingu; K Yoshioka; M Nobunaga; K Yoshida
Journal:  Inflammation       Date:  1985-09       Impact factor: 4.092

8.  Plasminogen activation in plasma of patients with systemic lupus erythematosus.

Authors:  N Negoro; Y Kanayama; T Takeda; M Fujisawa; M Okamura; T Inoue
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

9.  Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils.

Authors:  M Shingu; S Nonaka; H Nishimukai; M Nobunaga; H Kitamura; K Tomo-Oka
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

10.  Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes.

Authors:  Line Kjær Winberg; Søren Jacobsen; Claus H Nielsen
Journal:  Arthritis Res Ther       Date:  2017-10-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.